联邦药物和儿童滥用法实施中的州政策差异以及阿片类药物使用障碍孕妇和产后个体的污名化。

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
MacKenzie R Peltier, Destiny D Pegram, Geetanjali Chander, Constance M Weisner, Sherry A McKee, Hendree E Jones, Grace Chang
{"title":"联邦药物和儿童滥用法实施中的州政策差异以及阿片类药物使用障碍孕妇和产后个体的污名化。","authors":"MacKenzie R Peltier, Destiny D Pegram, Geetanjali Chander, Constance M Weisner, Sherry A McKee, Hendree E Jones, Grace Chang","doi":"10.1089/jwh.2024.0638","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Importance:</i></b> Despite increased initiatives and funding to improve access to evidence-based treatments for opioid use disorder (OUD), including medications for OUD (mOUD), pregnant/postpartum individuals have significant obstacles to accessing these life-saving medications. <b><i>Observations:</i></b> Current legislation, specifically the <i>Comprehensive Addiction and Recovery Act (CARA)</i>, mandates that the Governor of each state has systems in place to identify and address the needs of substance-exposed infants. However, this legislation removed the word \"illegal\" when defining substance use and left other important words in the law up to each individual state to define. These changes resulted in pregnant/postpartum individuals with OUD who were receiving legally prescribed mOUD, being subject to legal actions. In many states, such notifications result in investigation and punitive actions, which may include the removal of children from the care of postpartum individuals. These state policies have created additional barriers to accessing mOUD for pregnant and/or postpartum individuals. Research has demonstrated that pregnant individuals delay and/or avoid recommended prenatal care or decide to stop taking mOUD altogether, to prevent potential legal and child welfare-related consequences. This situation is problematic as it places individuals at risk of overdose and death and infants at risk of health complications. Importantly, such policies are subject to bias and disproportionately impact individuals of color and those from lower socioeconomic backgrounds. <b><i>Conclusions and Relevance:</i></b> The need to address and change the criminalization of pregnant/postpartum substance use laws to not penalize individuals adhering to the recommended standard of evidence-based care is urgent. Specific recommendations include: not relying on toxicology testing, reinstating \"illegal/non-prescribed\" language in legislation, implementing Plans of Safe Care, use of a two \"track\" reporting system, and federal support for states complying with Child Abuse Prevention and Treatment Act Reauthorization of 2010 (CAPTA) laws, increasing resources to improve outcomes for infants/postpartum individuals with OUD, and additional mandated training to educate key individuals, such as hospital/outpatient clinic providers and child-welfare workers.</p>","PeriodicalId":17636,"journal":{"name":"Journal of women's health","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.\",\"authors\":\"MacKenzie R Peltier, Destiny D Pegram, Geetanjali Chander, Constance M Weisner, Sherry A McKee, Hendree E Jones, Grace Chang\",\"doi\":\"10.1089/jwh.2024.0638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Importance:</i></b> Despite increased initiatives and funding to improve access to evidence-based treatments for opioid use disorder (OUD), including medications for OUD (mOUD), pregnant/postpartum individuals have significant obstacles to accessing these life-saving medications. <b><i>Observations:</i></b> Current legislation, specifically the <i>Comprehensive Addiction and Recovery Act (CARA)</i>, mandates that the Governor of each state has systems in place to identify and address the needs of substance-exposed infants. However, this legislation removed the word \\\"illegal\\\" when defining substance use and left other important words in the law up to each individual state to define. These changes resulted in pregnant/postpartum individuals with OUD who were receiving legally prescribed mOUD, being subject to legal actions. In many states, such notifications result in investigation and punitive actions, which may include the removal of children from the care of postpartum individuals. These state policies have created additional barriers to accessing mOUD for pregnant and/or postpartum individuals. Research has demonstrated that pregnant individuals delay and/or avoid recommended prenatal care or decide to stop taking mOUD altogether, to prevent potential legal and child welfare-related consequences. This situation is problematic as it places individuals at risk of overdose and death and infants at risk of health complications. Importantly, such policies are subject to bias and disproportionately impact individuals of color and those from lower socioeconomic backgrounds. <b><i>Conclusions and Relevance:</i></b> The need to address and change the criminalization of pregnant/postpartum substance use laws to not penalize individuals adhering to the recommended standard of evidence-based care is urgent. Specific recommendations include: not relying on toxicology testing, reinstating \\\"illegal/non-prescribed\\\" language in legislation, implementing Plans of Safe Care, use of a two \\\"track\\\" reporting system, and federal support for states complying with Child Abuse Prevention and Treatment Act Reauthorization of 2010 (CAPTA) laws, increasing resources to improve outcomes for infants/postpartum individuals with OUD, and additional mandated training to educate key individuals, such as hospital/outpatient clinic providers and child-welfare workers.</p>\",\"PeriodicalId\":17636,\"journal\":{\"name\":\"Journal of women's health\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of women's health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/jwh.2024.0638\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of women's health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/jwh.2024.0638","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

重要性:尽管增加了倡议和资金,以改善获得阿片类药物使用障碍(OUD)的循证治疗,包括OUD药物,但孕妇/产后个体在获得这些救命药物方面存在重大障碍。观察:目前的立法,特别是《综合成瘾和康复法》(CARA),要求各州州长建立适当的系统来识别和解决接触物质的婴儿的需求。然而,这项立法在定义物质使用时删除了“非法”一词,并将法律中的其他重要词语留给了每个州来定义。这些变化导致孕妇/产后服用法定药物的OUD患者受到法律诉讼。在许多州,这种通知导致调查和惩罚行动,其中可能包括将儿童从产后个人的照顾中移走。这些国家政策为孕妇和/或产后个体获得mod设置了额外的障碍。研究表明,孕妇推迟和/或避免建议的产前护理,或决定完全停止服用mod,以防止潜在的法律和儿童福利相关后果。这种情况是有问题的,因为它使个人面临服药过量和死亡的风险,使婴儿面临健康并发症的风险。重要的是,这些政策受到偏见的影响,对有色人种和社会经济背景较低的人产生了不成比例的影响。结论和相关性:迫切需要解决和改变怀孕/产后药物使用的刑事化法律,以不惩罚坚持循证护理推荐标准的个人。具体建议包括:不依赖毒理学测试,在立法中恢复“非法/非处方”语言,实施安全护理计划,使用双“轨道”报告系统,以及联邦政府支持各州遵守2010年《儿童虐待预防和治疗法案》(CAPTA)法律,增加资源以改善患有OUD的婴儿/产后个体的结果,并增加强制性培训以教育关键个体,例如医院/门诊服务提供者和儿童福利工作者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.

Importance: Despite increased initiatives and funding to improve access to evidence-based treatments for opioid use disorder (OUD), including medications for OUD (mOUD), pregnant/postpartum individuals have significant obstacles to accessing these life-saving medications. Observations: Current legislation, specifically the Comprehensive Addiction and Recovery Act (CARA), mandates that the Governor of each state has systems in place to identify and address the needs of substance-exposed infants. However, this legislation removed the word "illegal" when defining substance use and left other important words in the law up to each individual state to define. These changes resulted in pregnant/postpartum individuals with OUD who were receiving legally prescribed mOUD, being subject to legal actions. In many states, such notifications result in investigation and punitive actions, which may include the removal of children from the care of postpartum individuals. These state policies have created additional barriers to accessing mOUD for pregnant and/or postpartum individuals. Research has demonstrated that pregnant individuals delay and/or avoid recommended prenatal care or decide to stop taking mOUD altogether, to prevent potential legal and child welfare-related consequences. This situation is problematic as it places individuals at risk of overdose and death and infants at risk of health complications. Importantly, such policies are subject to bias and disproportionately impact individuals of color and those from lower socioeconomic backgrounds. Conclusions and Relevance: The need to address and change the criminalization of pregnant/postpartum substance use laws to not penalize individuals adhering to the recommended standard of evidence-based care is urgent. Specific recommendations include: not relying on toxicology testing, reinstating "illegal/non-prescribed" language in legislation, implementing Plans of Safe Care, use of a two "track" reporting system, and federal support for states complying with Child Abuse Prevention and Treatment Act Reauthorization of 2010 (CAPTA) laws, increasing resources to improve outcomes for infants/postpartum individuals with OUD, and additional mandated training to educate key individuals, such as hospital/outpatient clinic providers and child-welfare workers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of women's health
Journal of women's health 医学-妇产科学
CiteScore
6.60
自引率
5.70%
发文量
197
审稿时长
2 months
期刊介绍: Journal of Women''s Health is the primary source of information for meeting the challenges of providing optimal health care for women throughout their lifespan. The Journal delivers cutting-edge advancements in diagnostic procedures, therapeutic protocols for the management of diseases, and innovative research in gender-based biology that impacts patient care and treatment. Journal of Women’s Health coverage includes: -Internal Medicine Endocrinology- Cardiology- Oncology- Obstetrics/Gynecology- Urogynecology- Psychiatry- Neurology- Nutrition- Sex-Based Biology- Complementary Medicine- Sports Medicine- Surgery- Medical Education- Public Policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信